Skip to main navigation Skip to search Skip to main content

Furosemide does not prevent indomethacin-induced renal side effects in preterm infants

Research output: Contribution to journalArticle

Abstract

To determine whether furosemide could prevent renal side effects of indomethacin (INN, indometacin) used for the pharmacologic closure of the patent ductus arteriosus (PDA) in preterm infants.
Original languageEnglish
Pages (from-to)181-186
Number of pages6
JournalCLINICAL PHARMACOLOGY & THERAPEUTICS
Volume62
DOIs
Publication statusPublished - 1997

Keywords

  • Body Weight
  • Cyclooxygenase Inhibitors
  • Diuretics
  • Ductus Arteriosus, Patent
  • Female
  • Furosemide
  • Gestational Age
  • Glomerular Filtration Rate
  • Humans
  • Indomethacin
  • Infant, Newborn
  • Infant, Premature
  • Kidney
  • Kidney Diseases
  • Male
  • Urination

Fingerprint

Dive into the research topics of 'Furosemide does not prevent indomethacin-induced renal side effects in preterm infants'. Together they form a unique fingerprint.

Cite this